Avacc 10
Alternative Names: Avacc-10; COVID 2019 vaccine - Intravacc; CovOMV - IntravaccLatest Information Update: 28 Jul 2026
At a glance
- Originator Intravacc
- Class COVID-19 vaccines; Subunit vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - COVID 2019 infections
Highest Development Phases
- No development reported COVID 2019 infections
Most Recent Events
- 28 Jul 2026 No recent reports of development identified for phase-I development in COVID-2019-infections(Prevention) in Australia (Intranasal, Spray)
- 01 Jul 2026 Adverse event and immunogenicity data from phase I trial in COVID-2019 infections (Prevention) released by AdJane
- 15 Jan 2024 Intravacc completes a phase I trial in COVID-2019 infections (Prevention) in Australia (Intranasal) (NCT05604690)